Login to Your Account



BIO 2012

Post-Merger, Biotechs, Pharmas Need Strategy to Sync R&D

By Marie Powers
Staff Writer

Thursday, June 21, 2012
BOSTON – Since the BIO International Convention was last held in Boston in 2007, the number of publicly traded biotech companies has declined by 35 percent, from 394 to 255, David Thomas, BIO's director of industry research and analysis, told conference attendees Wednesday morning.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription